Literature DB >> 29793419

Role of MicroRNA in the Diagnosis and Therapy of Hepatic Metastases from Colorectal Cancer.

Angeliki Chorti1, Petros Bangeas1, Theodossis S Papavramidis1, Georgios Tsoulfas2.   

Abstract

INTRODUCTION: Colorectal cancer is one of the most common malignancies in both genders and liver metastasis appear in more than 50% of patients with colorectal cancer, worsening its morbidity and mortality rates. The existing methods for the diagnosis and prognosis of colorectal cancer seem to be insufficient to predict its aggressiveness, leading to poor outcomes for the patient.
OBJECTIVE: MicroRNAs are small non-coding RNAs, which interact with mRNAs in a posttranscriptional stage, and have been found to be involved in pathogenesis of cancer and its metastases. Their utility in diagnosis of colorectal liver metastasis gains ground through serum or tissue examination.
METHODS: Several miRNAs are related to colorectal cancer and its liver metastasis.
CONCLUSION: Some of them have oncogenic and other tumor suppressive role in the development of colorectal liver metastasis, while many of them have been proved to be correlated with the overall survival and prognosis of patients with colorectal cancer. The aim of the present review is to give a detailed account of the different miRNAs that have been described as playing a role in hepatic metastases from colorectal cancer, emphasizing their diagnostic, prognostic and therapeutic implications. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Colorectal cancer prognosis; colorectal cancer; colorectal hepatic metastases; colorectal liver metastasis; microRNAs; therapeutic implications.

Mesh:

Substances:

Year:  2018        PMID: 29793419     DOI: 10.2174/2211536607666180525073302

Source DB:  PubMed          Journal:  Microrna


  2 in total

1.  MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeability.

Authors:  Yu Li; Huibiao Zhang; Lei Fan; Jiahui Mou; Yue Yin; Chao Peng; Yuxiang Chen; Henglei Lu; Liting Zhao; Zhouteng Tao; Jing Chen; Yizheng Wang; Xinming Qi; Ruimin Huang; Jin Ren
Journal:  Oncogene       Date:  2020-02-27       Impact factor: 9.867

2.  Development of a 21-miRNA Signature Associated With the Prognosis of Patients With Bladder Cancer.

Authors:  Xiao-Hong Yin; Ying-Hui Jin; Yue Cao; York Wong; Hong Weng; Chao Sun; Jun-Hao Deng; Xian-Tao Zeng
Journal:  Front Oncol       Date:  2019-08-07       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.